Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | PDE4A | P27815 | 1/20 | 0.52 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL1933180 | 1.00 | TSHR (0.62) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL321623 | 0.89 | TSHR (0.50) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL30929982 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL28563108 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL44491 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL7030045 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL4671978 | 0.83 | LMNA (0.69) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL28441863 | 0.81 | PDE4A (0.67) | TSHRLMNAPDE4AOR51E2CYP2C9 | |
| Oxalic Acid SCHEMBL28462689 | 0.80 | LMNA (0.64) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Oxalic Acid SCHEMBL4365172 | 0.80 | LMNA (0.64) | TSHRLMNAALDH1A1PDE4AOR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119431731-A | Bio-based PDI (polymer dispersed) aqueous polyurethane emulsion as well as preparation method and application thereof | 东莞长联新材料科技股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-115594808-B | Bio-based anionic waterborne polyurethane and preparation method and application thereof | 亚士防水科技(滁州)有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-113875986-A | Antioxidant multilayer embedded probiotic particle and manufacturing method thereof | 葡萄王生技股份有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-103432091-A | Improved-performance tablet and preparation method thereof | ZHONG SHUGUANG | 2013-12-11 | — | — | CN | claimed |
| CN-102258785-A | Slow-release drug carrier | — | 2011-11-30 | — | — | CN | claimed |
| CN-102000339-A | Drug carrier capable of realizing sustained release of drug | SHUGUANG ZHONG | 2011-04-06 | — | — | CN | claimed |
| CN-101983723-A | Slow-release medicine carrier | SHUGUANG ZHONG | 2011-03-09 | — | — | CN | claimed |
| JP-4306298-A | — | — | None | — | — | JP | disclosed |
| JP-4353600-A | — | — | None | — | — | JP | disclosed |
| CN-119431731-A | Bio-based PDI (polymer dispersed) aqueous polyurethane emulsion as well as preparation method and application thereof | 东莞长联新材料科技股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-113164357-B | Use of polycarboxylic acid compounds for treating fibrous substrates based on amino acids, in particular hair | 迈图高新材料公司 | 2024-12-10 | — | — | CN | disclosed |
| CN-113166370-B | Polycarboxylic acid compounds for treating fibrous substrates based on amino acids, in particular hair | 迈图高新材料公司 | 2024-11-15 | — | — | CN | disclosed |
| US-11986521-B2 | Viral particle-based vaccine | VAKZINE PROJEKT MANAGEMENT GMBH (DE) | 2024-05-21 | — | — | US | disclosed |
| US-6713070-B1 | Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine | PLACHTER BODO (DE) | 2004-03-30 | — | — | US | disclosed |
| WO-2003062408-A1 | VIRUS-LIKE PARTICLES | NATURAL ENVIRONMENT RESEARCH COUNCIL (GB) | 2003-07-31 | — | — | WO | disclosed |
| WO-2001038341-A1 | POLYNUCLEOTIDE LIGANDS AS ANTI-VIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-05-31 | — | — | WO | disclosed |
| US-6156807-A | Powdered emulsifier composition and process for producing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-12-05 | — | — | US | disclosed |
| EP-0904830-A1 | Powdered emulsifier composition and process for making the same | Mitsubishi Chemical Corporation (JP) | 1999-03-31 | — | — | EP | disclosed |
| JP-H04353600-A | DRY-FINISHING AGENT COMPOSITION | KAO CORP | 1992-12-08 | — | — | JP | disclosed |
| JP-H04306298-A | DRY FINISHING AGENT COMPOSITION | KAO CORP | 1992-10-29 | — | — | JP | disclosed |